Eric Villalón

476 total citations
24 papers, 380 citations indexed

About

Eric Villalón is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eric Villalón has authored 24 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Genetics and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eric Villalón's work include Neurogenetic and Muscular Disorders Research (15 papers), Muscle Physiology and Disorders (10 papers) and RNA modifications and cancer (9 papers). Eric Villalón is often cited by papers focused on Neurogenetic and Muscular Disorders Research (15 papers), Muscle Physiology and Disorders (10 papers) and RNA modifications and cancer (9 papers). Eric Villalón collaborates with scholars based in United States, China and United Kingdom. Eric Villalón's co-authors include Christian L. Lorson, Erkan Y. Osman, Samantha L. Sison, Allison D. Ebert, Michael L. Garcia, Teresa N. Patitucci, C E Smith, Maria R. Jones, DDW Cornelison and Monir Shababi and has published in prestigious journals such as Scientific Reports, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Eric Villalón

24 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Villalón United States 12 274 243 72 69 58 24 380
Paola Rinchetti Italy 11 234 0.9× 167 0.7× 68 0.9× 77 1.1× 47 0.8× 16 339
Marta Jurek Poland 9 193 0.7× 118 0.5× 51 0.7× 83 1.2× 80 1.4× 24 345
Hannah K. Shorrock United Kingdom 13 416 1.5× 353 1.5× 99 1.4× 71 1.0× 111 1.9× 22 543
Eric M. Roskelley United States 4 315 1.1× 282 1.2× 73 1.0× 98 1.4× 95 1.6× 4 482
Monica Bucchia Italy 9 229 0.8× 174 0.7× 80 1.1× 113 1.6× 29 0.5× 10 342
Chitra C. Iyer United States 11 327 1.2× 249 1.0× 31 0.4× 40 0.6× 91 1.6× 17 462
Yaniv Gil Israel 9 308 1.1× 69 0.3× 53 0.7× 84 1.2× 44 0.8× 11 445
Katja Grohmann Germany 8 349 1.3× 388 1.6× 134 1.9× 88 1.3× 132 2.3× 8 530
Laura Torres‐Benito Germany 14 578 2.1× 507 2.1× 73 1.0× 59 0.9× 151 2.6× 15 679

Countries citing papers authored by Eric Villalón

Since Specialization
Citations

This map shows the geographic impact of Eric Villalón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Villalón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Villalón more than expected).

Fields of papers citing papers by Eric Villalón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Villalón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Villalón. The network helps show where Eric Villalón may publish in the future.

Co-authorship network of co-authors of Eric Villalón

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Villalón. A scholar is included among the top collaborators of Eric Villalón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Villalón. Eric Villalón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villalón, Eric, et al.. (2022). A combinatorial approach increases SMN level in SMA model mice. Human Molecular Genetics. 31(17). 2989–3000. 4 indexed citations
2.
Smith, C E, Monique A. Lorson, Jiude Mao, et al.. (2021). The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects. Human Molecular Genetics. 31(8). 1293–1307. 13 indexed citations
3.
Shababi, Monir, et al.. (2021). Defining the optimal dose and therapeutic window in SMA with respiratory distress type I model mice, FVB/NJ-Ighmpb2. Molecular Therapy — Methods & Clinical Development. 23. 23–32. 5 indexed citations
4.
Villalón, Eric, et al.. (2020). AAV9-DOK7 gene therapy reduces disease severity in Smn SMA model mice. Biochemical and Biophysical Research Communications. 530(1). 107–114. 22 indexed citations
5.
Osman, Erkan Y., Eric Villalón, Sarah Tisdale, et al.. (2019). Functional characterization of SMN evolution in mouse models of SMA. Scientific Reports. 9(1). 9472–9472. 11 indexed citations
6.
Shababi, Monir, C E Smith, Eric Villalón, et al.. (2019). Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd. Biochemical and Biophysical Research Communications. 520(2). 341–346. 10 indexed citations
7.
Villalón, Eric, et al.. (2019). Muscle fiber-type selective propensity to pathology in the nmd mouse model of SMARD1. Biochemical and Biophysical Research Communications. 516(1). 313–319. 3 indexed citations
8.
Garcia, Virginia B., John Snyder, Maria R. Jones, et al.. (2019). Lumbar spinal cord microglia exhibited increased activation in aging dogs compared with young adult dogs. GeroScience. 42(1). 169–182. 9 indexed citations
9.
Villalón, Eric, Rachel Kline, C E Smith, et al.. (2019). AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy. Human Molecular Genetics. 28(22). 3742–3754. 21 indexed citations
10.
Villalón, Eric, Devin M. Barry, Katie Frizzi, et al.. (2018). Internode length is reduced during myelination and remyelination by neurofilament medium phosphorylation in motor axons. Experimental Neurology. 306. 158–168. 15 indexed citations
11.
Shababi, Monir, et al.. (2018). A Direct Comparison of IV and ICV Delivery Methods for Gene Replacement Therapy in a Mouse Model of SMARD1. Molecular Therapy — Methods & Clinical Development. 10. 348–360. 10 indexed citations
12.
Snyder, John, Maria R. Jones, Virginia B. Garcia, et al.. (2018). Arginase-1 expressing microglia in close proximity to motor neurons were increased early in disease progression in canine degenerative myelopathy, a model of amyotrophic lateral sclerosis. Molecular and Cellular Neuroscience. 88. 148–157. 11 indexed citations
13.
Sison, Samantha L., et al.. (2017). Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy. Human Molecular Genetics. 26(17). 3409–3420. 62 indexed citations
14.
Villalón, Eric, et al.. (2017). Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy. JCI Insight. 2(5). e89970–e89970. 56 indexed citations
15.
Villalón, Eric, et al.. (2017). Selective vulnerability in neuronal populations in nmd/SMARD1 mice. Human Molecular Genetics. 27(4). 679–690. 16 indexed citations
16.
Shababi, Monir, Zhihua Feng, Eric Villalón, et al.. (2016). Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent. Molecular Therapy. 24(5). 855–866. 31 indexed citations
17.
Jones, Maria R., Eric Villalón, & Michael L. Garcia. (2015). Genetic Manipulation of Neurofilament Protein Phosphorylation. Methods in enzymology on CD-ROM/Methods in enzymology. 568. 461–476. 3 indexed citations
18.
Villalón, Eric, et al.. (2015). Exacerbation of Charcot–Marie–Tooth type 2E neuropathy following traumatic nerve injury. Brain Research. 1627. 143–153. 9 indexed citations
19.
Villalón, Eric, David J. Schulz, & Samuel T. Waters. (2013). Real-Time PCR Quantification of Gene Expression in Embryonic Mouse Tissue. Methods in molecular biology. 1092. 81–94. 2 indexed citations
20.
Villalón, Eric, et al.. (2012). Expressing hNF‐LE397K results in abnormal gaiting in a transgenic model of CMT2E. Genes Brain & Behavior. 11(3). 360–365. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Rinchetti Breakdown of academic impact, for papers by Marta Jurek Breakdown of academic impact, for papers by Hannah K. Shorrock Breakdown of academic impact, for papers by Eric M. Roskelley Breakdown of academic impact, for papers by Monica Bucchia Breakdown of academic impact, for papers by Chitra C. Iyer Breakdown of academic impact, for papers by Yaniv Gil Breakdown of academic impact, for papers by Katja Grohmann Breakdown of academic impact, for papers by Laura Torres‐Benito
Rankless by CCL
2026